Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Health Services Research & Development

Go to the ORD website
Go to the QUERI website

RCD 03-176 – HSR&D Study

 
RCD 03-176
Pain, Sexual Dysfunction, and Depression in Hemodialysis Patients
Steven D. Weisbord MD MSc
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
Pittsburgh, PA
Funding Period: January 2005 - December 2011

BACKGROUND/RATIONALE:
There are currently over 500,000 individuals with end-stage renal disease in the United States, and more than 100,000 new patients develop this condition annually. Recent estimates suggest that more than 35,000 Veterans currently receive chronic hemodialysis. Although life-sustaining, hemodialysis is associated with substantial morbidity and mortality. With the recognition that providers have limited means beyond renal transplantation to prolong the lives of patients on hemodialysis, investigators are refocusing their research efforts on identifying interventions to improve patients' quality of life, which is substantially impaired in this population. Several major factors that contribute to poor quality of life have been identified, including the large burden of physical and emotional symptoms in this patient population. Of the many symptoms that affect patients on hemodialysis, pain, sexual dysfunction, and depression are among the most prevalent, severe, and highly correlated with impaired quality of life. These observations are particularly noteworthy with data documenting the safety and efficacy of pharmacologic therapy for these symptoms. Nonetheless, preliminary studies suggest that even when severe, these symptoms are untreated or under-treated in patients on hemodialysis. Therefore, efforts to identify and implement strategies to improve the management of pain, sexual dysfunction and depression in the hemodialysis population are needed.

OBJECTIVE(S):
The broad objective of this 3-year project was to determine the most effective strategy for the management of pain, sexual dysfunction, and depression in patients on chronic hemodialysis. In a randomized clinical trial of 245 patients receiving hemodialysis at 9 dialysis units, we compared two symptom management strategies: (a) providing feedback on patients' symptoms to renal providers along with evidence-based algorithms for their treatment and; (b) using renal symptom management nurses to identify and facilitate treatment of these symptoms. We hypothesized that having trained symptom management nurses facilitate the management of pain, sexual dysfunction,, and depression would result in greater improvement in these symptoms than a strategy of simply providing feedback on these symptoms to renal providers.

METHODS:
After enrollment, baseline data was collected from all patients during an observation period of 2 to 12 months. Pain, sexual dysfunction, depression were assessed monthly. Quality of life, overall symptom burden and satisfaction with care were assessed quarterly during this observation period.After the observational phase, patients were randomized into one of two study arms. One group was randomized to a "feedback intervention" in which renal providers received data on the presence and severity of patients' pain, sexual dysfunction, and depression along with algorithms for the treatment of these symptoms. Treatment decisions were left at the discretion of the provider(s). The other group was randomized to a "management intervention" in which renal symptom management nurses assessed these symptoms and facilitated the implementation of treatment for pain, sexual dysfunction, and depression.

FINDINGS/RESULTS:
Not yet available.

IMPACT:
By determining the most effective approach to the management of overall pain, sexual dysfunction, and depression, we hope to introduce a patient-centered management approach to improve the symptom burden and quality of life of Veterans receiving chronic hemodialysis. We also aim to determine which patients on chronic hemodialysis are most amenable to and likley to respond to more aggressive management of these three symptoms.


External Links for this Project

Dimensions for VA

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

If you have VA-Intranet access, click here for more information vaww.hsrd.research.va.gov/dimensions/

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.
    Search Dimensions for this project

PUBLICATIONS:

Journal Articles

  1. Weisbord SD, Palevsky PM. Acute kidney injury: intravenous fluid to prevent contrast-induced AKI. Nature reviews. Nephrology. 2009 May 1; 5(5):256-7. [view]
  2. Weisbord SD, Palevsky PM. Acute kidney injury: kidney injury after contrast media: marker or mediator? Nature reviews. Nephrology. 2010 Nov 1; 6(11):634-6. [view]
  3. Weisbord SD, Palevsky PM. Acute renal failure in the intensive care unit. Seminars in respiratory and critical care medicine. 2006 Jun 1; 27(3):262-273. [view]
  4. Weisbord SD, Chen H, Stone RA, Kip KE, Fine MJ, Saul MI, Palevsky PM. Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. Journal of the American Society of Nephrology : JASN. 2006 Oct 1; 17(10):2871-7. [view]
  5. Weisbord SD, Fried LF, Mor MK, Resnick AL, Kimmel PL, Palevsky PM, Fine MJ. Associations of race and ethnicity with anemia management among patients initiating renal replacement therapy. Journal of the National Medical Association. 2007 Nov 1; 99(11):1218-26. [view]
  6. Weisbord SD, Fried LF, Unruh ML, Kimmel PL, Switzer GE, Fine MJ, Arnold RM. Associations of race with depression and symptoms in patients on maintenance haemodialysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2007 Jan 1; 22(1):203-8. [view]
  7. Carreon M, Fried LF, Palevsky PM, Kimmel PL, Arnold RM, Weisbord SD. Clinical correlates and treatment of bone/joint pain and difficulty with sexual arousal in patients on maintenance hemodialysis. Hemodialysis international. International Symposium on Home Hemodialysis. 2008 Apr 1; 12(2):268-74. [view]
  8. Green SM, Selzer F, Mulukutla SR, Tadajweski EJ, Green JA, Wilensky RL, Laskey WK, Cohen HA, Rao SV, Weisbord SD, Lee JS, Reis SE, Kip KE, Kelsey SF, Williams DO, Marroquin OC. Comparison of bare-metal and drug-eluting stents in patients with chronic kidney disease (from the NHLBI Dynamic Registry). The American journal of cardiology. 2011 Dec 1; 108(11):1658-64. [view]
  9. Hanlon JT, Aspinall SL, Semla TP, Weisbord SD, Fried LF, Good CB, Fine MJ, Stone RA, Pugh MJ, Rossi MI, Handler SM. Consensus guidelines for oral dosing of primarily renally cleared medications in older adults. Journal of the American Geriatrics Society. 2009 Feb 1; 57(2):335-40. [view]
  10. Weisbord SD, Palevsky PM. Contrast-induced acute kidney injury: short- and long-term implications. Seminars in Nephrology. 2011 May 1; 31(3):300-9. [view]
  11. Weisbord SD, Bossola M, Fried LF, Giungi S, Tazza L, Palevsky PM, Arnold RM, Luciani G, Kimmel PL. Cultural comparison of symptoms in patients on maintenance hemodialysis. Hemodialysis international. International Symposium on Home Hemodialysis. 2008 Oct 1; 12(4):434-40. [view]
  12. Weisbord SD, Mor MK, Kim S, Hartwig KC, Sonel AF, Palevsky PM, Fine MJ. Factors associated with the use of preventive care for contrast-induced acute kidney injury. Journal of general internal medicine. 2009 Mar 1; 24(3):289-98. [view]
  13. Jhamb M, Weisbord SD, Steel JL, Unruh M. Fatigue in patients receiving maintenance dialysis: a review of definitions, measures, and contributing factors. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2008 Aug 1; 52(2):353-65. [view]
  14. Unruh ML, Weisbord SD, Kimmel PL. Health-related quality of life in nephrology research and clinical practice. Seminars in Dialysis. 2005 Mar 1; 18(2):82-90. [view]
  15. Weisbord SD, Kimmel PL. Health-related quality of life in the era of erythropoietin. Hemodialysis international. International Symposium on Home Hemodialysis. 2008 Jan 1; 12(1):6-15. [view]
  16. Soni RK, Weisbord SD, Unruh ML. Health-related quality of life outcomes in chronic kidney disease. Current Opinion in Nephrology and Hypertension. 2010 Mar 1; 19(2):153-9. [view]
  17. Jhamb M, Pike F, Ramer S, Argyropoulos C, Steel J, Dew MA, Weisbord SD, Weissfeld L, Unruh M. Impact of fatigue on outcomes in the hemodialysis (HEMO) study. American Journal of Nephrology. 2011 Oct 27; 33(6):515-23. [view]
  18. Weisbord SD, Mor MK, Resnick AL, Hartwig KC, Palevsky PM, Fine MJ. Incidence and outcomes of contrast-induced AKI following computed tomography. Clinical Journal of the American Society of Nephrology. 2008 Sep 1; 3(5):1274-81. [view]
  19. Weisbord SD. Iodinated contrast media and the kidney. Reviews in Cardiovascular Medicine. 2008 Jan 1; 9 Suppl 1:S14-23. [view]
  20. Weisbord SD, Palevsky PM. Iodinated contrast media and the role of renal replacement therapy. Advances in chronic kidney disease. 2011 May 1; 18(3):199-206. [view]
  21. Palevsky PM, Liu KD, Brophy PD, Chawla LS, Parikh CR, Thakar CV, Tolwani AJ, Waikar SS, Weisbord SD. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2013 May 1; 61(5):649-72. [view]
  22. Aslam N, Pesacreta M, Bastacky SI, McHale T, Huston A, Palevsky PM, Weisbord SD. Light chain-associated Fanconi syndrome with nephrotic-range proteinuria. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2006 Apr 1; 47(4):A57, e43-5. [view]
  23. Weisbord SD, Shields AM, Mor MK, Sevick MA, Homer M, Peternel J, Porter P, Rollman BL, Palevsky PM, Arnold RM, Fine MJ. Methodology of a randomized clinical trial of symptom management strategies in patients receiving chronic hemodialysis: the SMILE study. Contemporary clinical trials. 2010 Sep 1; 31(5):491-7. [view]
  24. Weisbord SD, Fried LF, Arnold RM, Fine MJ, Levenson DJ, Peterson RA, Switzer GE. Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. Journal of the American Society of Nephrology : JASN. 2005 Aug 1; 16(8):2487-94. [view]
  25. Weisbord SD, Palevsky P. Prevention of contrast-induced acute kidney injury. Journal of clinical outcomes management : JCOM. 2012 Apr 1; 19(4):178-191. [view]
  26. Weisbord SD, Palevsky PM. Prevention of contrast-induced nephropathy with volume expansion. Clinical Journal of the American Society of Nephrology. 2008 Jan 1; 3(1):273-80. [view]
  27. Weisbord SD, Mor MK, Resnick AL, Hartwig KC, Sonel AF, Fine MJ, Palevsky PM. Prevention, incidence, and outcomes of contrast-induced acute kidney injury. Archives of internal medicine. 2008 Jun 23; 168(12):1325-32. [view]
  28. Hudson M, Weisbord S, Arnold RM. Prognostication in patients receiving dialysis #191. Journal of palliative medicine. 2007 Dec 1; 10(6):1402-3. [view]
  29. Jasuja D, Mor MK, Hartwig KC, Palevsky PM, Fine MJ, Weisbord SD. Provider knowledge of contrast-induced acute kidney injury. The American journal of the medical sciences. 2009 Oct 1; 338(4):280-6. [view]
  30. Kimmel PL, Cohen SD, Weisbord SD. Quality of life in patients with end-stage renal disease treated with hemodialysis: survival is not enough! Journal of Nephrology. 2008 Mar 1; 21 Suppl 13:S54-8. [view]
  31. Weisbord SD, Palevsky PM. Radiocontrast-induced acute renal failure. Journal of Intensive Care Medicine. 2005 Mar 1; 20(2):63-75. [view]
  32. Cohen LM, Moss AH, Weisbord SD, Germain MJ. Renal palliative care. Journal of palliative medicine. 2006 Aug 1; 9(4):977-992. [view]
  33. Weisbord SD, Fried LF, Mor MK, Resnick AL, Unruh ML, Palevsky PM, Levenson DJ, Cooksey SH, Fine MJ, Kimmel PL, Arnold RM. Renal provider recognition of symptoms in patients on maintenance hemodialysis. Clinical Journal of the American Society of Nephrology. 2007 Sep 1; 2(5):960-7. [view]
  34. Seethala S, Hess R, Bossola M, Unruh ML, Weisbord SD. Sexual function in women receiving maintenance dialysis. Hemodialysis international. International Symposium on Home Hemodialysis. 2010 Jan 1; 14(1):55-60. [view]
  35. Roumelioti ME, Argyropoulos C, Buysse DJ, Nayar H, Weisbord SD, Unruh ML. Sleep Quality, Mood, Alertness and Their Variability in CKD and ESRD. Nephron. Clinical practice. 2011 Jul 27; 114(4):c277-c287. [view]
  36. Weisbord SD, Palevsky PM. Strategies for the prevention of contrast-induced acute kidney injury. Current Opinion in Nephrology and Hypertension. 2010 Nov 1; 19(6):539-49. [view]
  37. Abdel-Kader K, Unruh ML, Weisbord SD. Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. Clinical Journal of the American Society of Nephrology. 2009 Jun 1; 4(6):1057-64. [view]
  38. Weisbord SD. Symptoms and their correlates in chronic kidney disease. Advances in chronic kidney disease. 2007 Oct 1; 14(4):319-27. [view]
  39. Weisbord SD, Bernardini J, Mor MK, Hartwig KC, Nicoletta PJ, Palevsky PM, Piraino B. The effect of coronary angiography on residual renal function in patients on peritoneal dialysis. Clinical Cardiology. 2006 Nov 1; 29(11):494-7. [view]
  40. Weisbord SD, Hartwig KC, Sonel AF, Fine MJ, Palevsky P. The incidence of clinically significant contrast-induced nephropathy following non-emergent coronary angiography. Catheterization and Cardiovascular Interventions : Official Journal of The Society For Cardiac Angiography & Interventions. 2008 Jun 1; 71(7):879-85. [view]
  41. Claxton RN, Blackhall L, Weisbord SD, Holley JL. Undertreatment of symptoms in patients on maintenance hemodialysis. Journal of pain and symptom management. 2010 Feb 1; 39(2):211-8. [view]
Journal Other

  1. Marroquin OC, Weisbord S. Cardiovascular evaluation before renal transplantation: to cath or not to cath? [Editorial]. Clinical Journal of the American Society of Nephrology. 2011 Aug 1; 6(8):1807-9. [view]
  2. Capasso P, Weisbord SD. Comment on meta-analyses of trials comparing contrast media. Radiology. 2009 Jul 1; 252(1):316; author reply 316-7. [view]
  3. Palevsky PM, Weisbord SD. Critical care nephrology: it's not just acute kidney injury. [Letter to the Editor]. Journal of the American Society of Nephrology : JASN. 2009 Nov 1; 20(11):2281-2. [view]
  4. Okusa MD, Molitoris BA, Palevsky PM, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Faubel S, Kellum JA, Wald R, Chertow GM, Levin A, Waikar SS, Murray PT, Parikh CR, Shaw AD, Go AS, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene TH, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA. Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trials. Clinical Journal of the American Society of Nephrology. 2012 May 1; 7(5):851-5. [view]
  5. Palevsky PM, Molitoris BA, Okusa MD, Levin A, Waikar SS, Wald R, Chertow GM, Murray PT, Parikh CR, Shaw AD, Go AS, Faubel SG, Kellum JA, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene T, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA. Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clinical Journal of the American Society of Nephrology. 2012 May 1; 7(5):844-50. [view]
  6. Molitoris BA, Okusa MD, Palevsky PM, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene TH, Faubel SG, Kellum JA, Wald R, Chertow GM, Levin A, Waikar SS, Murray PT, Parikh CR, Shaw AD, Go AS, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA. Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings. Clinical Journal of the American Society of Nephrology. 2012 May 1; 7(5):856-60. [view]
  7. Weisbord SD. Female sexual dysfunction in ESRD: an underappreciated epidemic? Clinical Journal of the American Society of Nephrology. 2012 Jun 1; 7(6):881-3. [view]
  8. Weisbord SD, Ramkumar M, LaPidus SA, McBride DJ, Palevsky PM. Functional renal artery obstruction following percutaneous kidney biopsy [letter]. [Editorial]. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2005 Jun 1; 20(6):1274-1275. [view]
  9. Hanlon JT, Wang X, Handler SM, Weisbord S, Pugh MJ, Semla T, Stone RA, Aspinall SL. Potentially inappropriate prescribing of primarily renally cleared medications for older veterans affairs nursing home patients. [Abstract]. Journal of The American Medical Directors Association. 2011 Jun 1; 12(5):377-83. [view]
  10. Weisbord SD, McGill JB, Kimmel PL. Psychosocial factors in patients with chronic kidney disease [editorial]. [Editorial]. Advances in chronic kidney disease. 2007 Oct 1; 14(4):316-8. [view]
Book Chapters

  1. Sharfuddin A, Weisbord SD, Palevsky PM, Molitoris B. Acute kidney injury. In: Brenner BM, Chertow G, Marsden PA, Skorecki K, Taal M, Yu AS, editors. Brenner and Rector’s The Kidney. 9 ed. Philadelphia, PA: Saunders; 2011. Chapter 30. 1044-1099 p. [view]
  2. Weisbord SD, Palevsky PM. Acute renal failure. In: Conn’s Current Therapy 2007. Saunders; 2006. Chapter 10. [view]
  3. Weisbord SD, Palevsky PM. Acute renal failure. In: Conn’s Current Therapy 2008. Saunders; 2007. Chapter 10. Section 10 p. [view]
  4. Weisbord SD, Palevsky P. Contrast-induced acute kidney injury. In: Schrier RW, editor. Schrier's Diseases of the Kidney and Urinary Tract. Lippincott, Williams, and Wilkins; 2012. [view]
  5. Weisbord SD, Kimmel P. Erythropoietin and quality of life in chronic kidney disease. In: Handbook of Dialysis Therapy. 4 ed. Elsevier; 2007. Chapter 20. 63-64 p. [view]
Center Products

  1. Weeks C, Weisbord SD. CHERP Policy Brief: Beyond lab data - symptoms matter for hemodialysis patients. 2008 Jan 1; 4(2). [view]
  2. Weisbord SD, Palevsky P. Practical strategies to prevent contrast-induced nephropathy in US Nephrology Touch Briefings. 2008 Aug 1; 4(1). [view]
VA Cyberseminars

  1. Weisbord SD. Assessment and management of symptom in patients on dialysis. [Cyberseminar]. 2010 Mar 24. [view]
Conference Presentations

  1. Weisbord SD. Academic nephrology: lessons learned by a junior investigator. Paper presented at: Mid-Atlantic Young Nephrology Investigators Forum; 2009 Mar 1; Baltimore, MD. [view]
  2. Fried LF, Weisbord SD, Chen H, Mor MK, Hanlon JT, Cunningham F, Good CB, Fine MJ. Age disparities with evaluation by nephrology for chronic kidney disease. Poster session presented at: American Society of Nephrology Renal Week Annual Meeting; 2007 Oct 31; San Francisco, CA. [view]
  3. Weisbord SD. Assessment and management of symptoms in patients with end-stage renal disease. Paper presented at: National Hospice and Palliative Care Organization Conference; 2009 Sep 24; Denver, CO. [view]
  4. Weisbord SD, Fried LF, Mor MK, Chen H, Law A. Association of race with achieved hemoglobin levels in veterans with chronic kidney disease receiving erythropoiesis stimulating agents. Poster session presented at: American Society of Nephrology Renal Week Annual Meeting; 2007 Oct 31; San Francisco, CA. [view]
  5. Law A, Fried LF, Mor MK, Chen H, Weisbord SD. Association of race with anemia management in veterans with chronic kidney disease. Poster session presented at: American Society of Health-System Pharmacists Clinical Midyear Meeting; 2007 Jun 25; San Francisco, CA. [view]
  6. Weisbord SD, Fried LF, Mor MK, Chen H, del Aguila M. Association of race with utilization and dose of erythropoiesis stimulating agents in veterans with chronic kidney disease. Poster session presented at: American Society of Nephrology Renal Week Annual Meeting; 2007 Oct 31; San Francisco, CA. [view]
  7. Fried LF, Weisbord SD, Chen H, Mor M, Hanlon JT, Cunningham F, Good CB, Fine MJ. Associations of race and age with nephrology evaluation for chronic kidney disease. Poster session presented at: American Society of Nephrology Renal Week Annual Meeting; 2007 Oct 31; San Francisco, CA. [view]
  8. Weisbord SD. Bicarbonate, saline, and NAC in the prevention of contrast-induced acute kidney injury: an analysis of the meta-analyses. Paper presented at: American Society of Nephrology Renal Week Annual Meeting; 2010 Nov 18; Denver, CO. [view]
  9. Hanlon JT, Aspinall S, Handler S, Rossi M, Good CB, Fine MJ, Fried L, Weisbord SD, Stone RA, Pugh MJ, Semla T. Consensus guidelines for dosing primarily renally cleared medications in older outpatients. Presented at: American Geriatrics Society Annual Meeting; 2008 May 1; Washington, DC. [view]
  10. Weisbord SD. Contrast induced acute kidney injury – can we prevent it and does it matter? [invited presentation]. Presented at: American Society of Nephrology Renal Week Annual Meeting; 2011 Nov 8; Philadelphia, PA. [view]
  11. Weisbord SD. Contrast-induced acute kidney injury. Paper presented at: American Society of Nephrology Renal Week Annual Meeting; 2008 Nov 4; Philadelphia, PA. [view]
  12. Weisbord SD. Contrast-induced acute kidney injury: mortality risk and prevention. Paper presented at: National Kidney Foundation Clinical Spring Meeting; 2009 Mar 25; Nashville, TN. [view]
  13. Weisbord SD. Contrast-induced nephropathy. Paper presented at: American Society of Nephrology Renal Week Annual Meeting; 2009 Oct 28; San Diego, CA. [view]
  14. Weisbord SD. Contrast-induced nephropathy: Can we prevent it? Does it matter? Paper presented at: American Society of Nephrology Renal Week Annual Meeting; 2010 Nov 17; Denver, CO. [view]
  15. Weisbord SD. CT or MRI in the patient with advanced CKD: is there a right answer? Paper presented at: World Congress of Nephrology; 2009 May 22; Milan, Italy. [view]
  16. Green J, Mor MK, Shields A, Porter P, Palevsky P, Fine MJ, Arnold RM, Weisbord SD. Health literacy in hemodialysis patients. Poster session presented at: American Society of Nephrology Renal Week Annual Meeting; 2009 Oct 30; San Diego, CA. [view]
  17. Weisbord SD. Making sense of the evidence with contrast-induced nephropathy. Paper presented at: World Congress of Nephrology; 2007 Apr 22; Rio de Janeiro, Brazil. [view]
  18. Weisbord SD. Management of the critically ill ESRD patient. Paper presented at: National Kidney Foundation Clinical Spring Meeting; 2009 Mar 24; Nashville, TN. [view]
  19. Weisbord SD. Nephrogenic systemic fibrosis and the role of gadolinium-based contrast agents in magnetic resonance practice: patient based management strategies. Paper presented at: European Society for Magnetic Resonance in Medicine and Biology Annual Congress; 2008 Oct 2; Valencia, Spain. [view]
  20. Weisbord SD. NSF: Understanding causal mechanisms and patient based management strategies. Paper presented at: World Congress of Nephrology; 2009 May 22; Milan, Italy. [view]
  21. Weisbord SD. Pain in ESRD. Paper presented at: National Kidney Foundation Clinical Spring Meeting; 2009 Mar 26; Nashville, TN. [view]
  22. Weisbord SD. Prevention of contrast-induced acute kidney injury. Paper presented at: National Kidney Foundation Clinical Spring Meeting; 2011 Apr 27; Las Vegas, NV. [view]
  23. Hanlon JT, Wang X, Handler SM, Weisbord SD, Semla TP, Stone RA, Aspinall SL. Suboptimal prescribing of primarily renally cleared medications for older VA nursing home (NH) patients. Poster session presented at: American Geriatrics Society Annual Meeting; 2010 May 15; Orlando, FL. [view]
  24. Weisbord SD. Symptoms among patients not on dialysis--does eGFR matter? Or is it proteinuria? Paper presented at: American Society of Nephrology Renal Week Annual Meeting; 2010 Nov 20; Denver, CO. [view]
  25. Weisbord SD. Understanding risk factors for NSF to guide preventive care in patients with kidney disease. Paper presented at: European Society of Radiology Annual Congress; 2009 Mar 6; Vienna, Austria. [view]
  26. Weisbord SD. Update in nephrology: contrast induced nephropathy, nephrogenic systemic fibrosis and acute phosphate nephropathy. Paper presented at: American College of Physicians New Mexico Chapter Annual Meeting; 2010 Oct 26; Albuquerque, NM. [view]
  27. Fried LF, Weisbord SD, Chen H, Mor M, Hanlon JT, Cunningham F, Good CB, Fine MJ. Use of angiotensin converting enzyme (ACEI) or angiotensin receptor blockers (ARB) in chronic kidney disease in the VA. Poster session presented at: American Society of Nephrology Renal Week Annual Meeting; 2007 Oct 31; San Francisco, CA. [view]
  28. McCullough PA, Brown J, Weisbord SD. When to assess renal function prior to CT to determine risk for contrast-induced nephropathy. Paper presented at: International Society for Computed Tomography International Symposium; 2010 May 18; San Francisco, CA. [view]
  29. Weisbord SD. Which patients are at risk for clinically significant contrast-induced nephropathy following computed tomography. Paper presented at: International Society for Computed Tomography International Symposium; 2010 May 18; San Francisco, CA. [view]


DRA: Mental, Cognitive and Behavioral Disorders, Health Systems, Kidney Disorders
DRE: Etiology, Treatment - Observational, Treatment - Comparative Effectiveness
Keywords: none
MeSH Terms: none

Questions about the HSR&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.